Scientists identify parts of virus which may lead to vaccine

Experts from both the University of Nottingham and Nottingham Trent University will be assisting a company which develops immunotherapies for the treatment of cancer.

They will be adapting its cancer vaccine to develop a new vaccine to prevent future infection by the novel coronavirus, which causes covid-19.